WENDY FASANO: Open Payments
NPI 1073094975 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,946 in 114 payments from 25 companies in 2025. Trend: 2023 $1,725 · 2024 $1,803 · 2025 $1,946
Food & beverage: $1,946
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $349 |
| GlaxoSmithKline, LLC. | 16 | $218 |
| AstraZeneca Pharmaceuticals LP | 5 | $188 |
| Lilly USA, LLC | 10 | $170 |
| Bayer Healthcare Pharmaceuticals Inc. | 22 | $165 |
| Antares Pharma, Inc. | 6 | $106 |
| Novo Nordisk Inc | 5 | $99 |
| Amgen Inc. | 6 | $95 |
| Exact Sciences Corporation | 3 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
Products named: JARDIANCE, Kerendia, PREVNAR 20, TRELEGY ELLIPTA, BREZTRI, XYOSTED, ELIQUIS, Ozempic.
Industry payments across TX — which companies pay providers there.
